Microbot Medical Inc.
Microbot Medical Inc. (MBOT): 2 pipeline candidates · ~42 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
41.7 months
D/E 0.05 · 0% dilution
Lead: Approved
2 candidates
N/A
N/A
A transparent, data-derived signal for Microbot Medical Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$126.3M
Cash
$3.7M
Quarterly Burn
$5.1M
Runway
41.7 mo
Revenue
$105K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
| Drug | Phase |
|---|---|
| liberty endovascular robotic surgical system | Approved |
| novacross | Preclinical |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
79
Total value held
$35.8M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 5,819,050 | $14.0M |
| susquehanna international group, llp | 1,140,707 | $2.7M |
| blackrock, inc. | 857,398 | $2.1M |
| geode capital management, llc | 760,831 | $1.8M |
| dnb asset management as | 677,498 | $1.6M |
| stifel financial corp | 573,075 | $1.4M |
| marshall wace, llp | 481,045 | $1.2M |
| ancora advisors llc | 477,080 | $1.1M |
| millennium management llc | 454,746 | $1.1M |
| vanguard fiduciary trust co | 400,225 | $965K |
Showing top 10 of 79 institutional holders of Microbot Medical Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Microbot Medical Inc.'s pipeline?
Microbot Medical Inc. (MBOT) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Microbot Medical Inc.'s lead drug candidate?
Microbot Medical Inc.'s most advanced tracked candidate is liberty endovascular robotic surgical system (Approved) for Endovascular interventional procedures, specifically peripheral vasculature.
What is Microbot Medical Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Microbot Medical Inc. has approximately 41.7 months of cash runway.
What is Microbot Medical Inc.'s market capitalization?
Microbot Medical Inc.'s market capitalization is approximately $126.3M.
Who is the CEO of Microbot Medical Inc.?
Mr. Harel Gadot is the chief executive officer of Microbot Medical Inc. (MBOT).
Get the full picture on Microbot Medical Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.